Reinduction Chemotherapy With Gemtuzumab Ozogamicin and Intermediate/High-Dose Cytarabine: A Single-Center Experience
Open Journal of Blood Diseases
doi 10.4236/ojbd.2014.41001
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2014
Authors
Publisher
Scientific Research Publishing, Inc.